16 patents
Utility
Early apoptotic cells for use in treating sepsis
7 Mar 23
Compositions disclosed herein, and methods of use thereof included those for treating or preventing sepsis in a subject in need, including methods of extending of the survival of a subject suffering from sepsis, and reduction of organ dysfunction or failure due to sepsis.
Shai Novik, Dror Mevorach
Filed: 28 May 20
Utility
Combination immune therapy and cytokine control therapy for cancer treatment
15 Nov 22
Compositions disclosed herein, and methods of use thereof included those for treating or preventing sepsis in a subject in need, including methods of extending of the survival of a subject suffering from sepsis, and reduction of organ dysfunction or failure due to sepsis.
Shai Novik, Dror Mevorach
Filed: 7 Oct 19
Utility
Therapeutic Apoptotic Cells for Treatment of Osteoarthritis
8 Sep 22
Methods of use for treating osteoarthritis or vanishing bone disease in a subject in need, including methods of direct administration of a composition of early apoptotic cells or an apoptotic supernatant into or adjacent to the affected joint or bone tissue.
Dror MEVORACH, Shai NOVIK
Filed: 23 Aug 20
Utility
Combination Immune Therapy and Cytokine Control Therapy for Cancer Treatment
5 May 22
Compositions disclosed herein, and methods of use thereof included those for treating or preventing sepsis in a subject in need, including methods of extending of the survival of a subject suffering from sepsis, and reduction of organ dysfunction or failure due to sepsis.
Shai Novik, Dror Mevorach
Filed: 4 Jan 22
Utility
Combination immune therapy and cytokine control therapy for cancer treatment
3 May 22
Compositions disclosed herein, and methods of use thereof included those for treating or preventing sepsis in a subject in need, including methods of extending of the survival of a subject suffering from sepsis, and reduction of organ dysfunction or failure due to sepsis.
Shai Novik, Dror Mevorach
Filed: 4 Nov 19
Utility
Combination immune therapy and cytokine control therapy for cancer treatment
19 Apr 22
Compositions disclosed herein, and methods of use thereof included those for treating or preventing sepsis in a subject in need, including methods of extending of the survival of a subject suffering from sepsis, and reduction of organ dysfunction or failure due to sepsis.
Shai Novik, Dror Mevorach
Filed: 19 Nov 18
Utility
Combination Immune Therapy and Cytokine Control Therapy for Cancer Treatment
29 Jul 21
Compositions disclosed herein, and methods of use thereof included those for inhibiting or reducing the incidence of cytokine release syndrome or cytokine storm in a subject undergoing CAR T-cell therapy, methods of treating a cancer or tumor, methods of reducing tumor load, methods of reducing the size or growth rate of a cancer or a tumor, and methods of extending of the survival of a subject suffering from a cancer or tumor, wherein the subjects are administered compositions comprising apoptotic cells or apoptotic cell supernatants.
Shai NOVIK, Dror MEVORACH
Filed: 5 Apr 21
Utility
Combination immune therapy and cytokine control therapy for cancer treatment
11 May 21
Compositions disclosed herein, and methods of use thereof included those for inhibiting or reducing the incidence of cytokine release syndrome or cytokine storm in a subject undergoing CAR T-cell therapy, methods of treating a cancer or tumor, methods of reducing tumor load, methods of reducing the size or growth rate of a cancer or a tumor, and methods of extending of the survival of a subject suffering from a cancer or tumor, wherein the subjects are administered compositions comprising apoptotic cells or apoptotic cell supernatants.
Shai Novik, Dror Mevorach
Filed: 24 Aug 17
Utility
Therapeutic apoptotic cell preparations, method for producing same and uses thereof
23 Feb 21
The present application provides pharmaceutical compositions comprising a population of mononuclear-enriched cells in an early-apoptotic state, methods for the production of said compositions and uses thereof in the treatment of diseases characterized by pathological immune responses.
Dror Mevorach, Inna Reiner
Filed: 29 Jul 18
Utility
Therapeutic Pooled Blood Apoptotic Cell Preparations and Uses Thereof
11 Feb 21
Cell preparations comprising a pooled and enriched, mononuclear apoptotic cell population, and a method of preparing this cell preparation are described.
Dror MEVORACH, Shai NOVIK
Filed: 21 Oct 20
Utility
Therapeutic pooled blood apoptotic cell preparations and uses thereof
7 Dec 20
Cell preparations comprising a pooled and enriched, mononuclear apoptotic cell population, and a method of preparing this cell preparation are described.
Dror Mevorach, Shai Novik
Filed: 20 Apr 16
Utility
Early Apoptotic Cells for Use In Treating Sepsis
16 Sep 20
Compositions disclosed herein, and methods of use thereof included those for treating or preventing sepsis in a subject in need, including methods of extending of the survival of a subject suffering from sepsis, and reduction of organ dysfunction or failure due to sepsis.
Shai NOVIK, Dror Mevorach
Filed: 27 May 20
Utility
Combination Immune Therapy and Cytokine Control Therapy for Cancer Treatment
22 Apr 20
Compositions disclosed herein, and methods of use thereof included those for treating or preventing sepsis in a subject in need, including methods of extending of the survival of a subject suffering from sepsis, and reduction of organ dysfunction or failure due to sepsis.
Shai NOVIK, Dror MEVORACH
Filed: 3 Nov 19
Utility
Combination Immune Therapy and Cytokine Control Therapy for Cancer Treatment
26 Feb 20
Compositions disclosed herein, and methods of use thereof included those for treating or preventing sepsis in a subject in need, including methods of extending of the survival of a subject suffering from sepsis, and reduction of organ dysfunction or failure due to sepsis.
Shai NOVIK, Dror MEVORACH
Filed: 6 Oct 19
Utility
Combination Immune Therapy and Cytokine Control Therapy for Cancer Treatment
8 Jan 20
Compositions disclosed herein, and methods of use thereof included those for inhibiting or reducing the incidence of cytokine release syndrome or cytokine storm in a subject undergoing CAR T-cell therapy, methods of treating a cancer or tumor, methods of reducing tumor load, methods of reducing the size or growth rate of a cancer or a tumor, and methods of extending of the survival of a subject suffering from a cancer or tumor, wherein the subjects are administered compositions comprising apoptotic cells or apoptotic cell supernatants.
Shai NOVIK, Dror MEVORACH
Filed: 18 Sep 19
Utility
Therapeutic Apoptotic Cells for Cancer Therapy
8 Jan 20
Methods of use of early apoptotic cell populations and compositions thereof disclosed herein, including methods of treating a cancer or a tumor, extending survival times of a subject suffering from a cancer or a tumor, and reducing the size or reducing the growth rate of a cancer or a tumor, wherein subjects are administered apoptotic cells or compositions thereof.
Shai NOVIK, Dror MEVORACH
Filed: 18 Sep 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first